Vitenskapelige artikler
Berge Gisle, Mælandsmo Gunhild M
Evaluation of potential interactions between the metastasis-associated protein S100A4 and the tumor suppressor protein p53.
Amino Acids 2011 Oct;41(4):863-73. Epub 2010 feb 24
- PMID:
- 20177948
Bergman Andries M, Adema Auke D, Balzarini Jan, Bruheim Skjalg, Fichtner Iduna, Noordhuis Paul, Fodstad Oystein, Myhren Finn, Sandvold Marit L, Hendriks Hans R, Peters Godefridus J
Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models.
Invest New Drugs 2010 Jan. Epub 2010 jan 12
- PMID:
- 20066470
Brekke Helge R, Ribeiro Franclim R, Kolberg Matthias, Agesen Trude H, Lind Guro E, Eknaes Mette, Hall Kirsten S, Bjerkehagen Bodil, van den Berg Eva, Teixeira Manuel R, Mandahl Nils, Smeland Sigbjørn, Mertens Fredrik, Skotheim Rolf I, Lothe Ragnhild A
Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group.
J Clin Oncol 2010 Mar;28(9):1573-82. Epub 2010 feb 16
- PMID:
- 20159821
Eide Marianne Brodtkorb, Liestøl Knut, Lingjaerde Ole Christian, Hystad Marit E, Kresse Stine H, Meza-Zepeda Leonardo, Myklebost Ola, Trøen Gunhild, Aamot Hege Vangstein, Holte Harald, Smeland Erlend Bremertun, Delabie Jan
Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones.
Blood 2010 Sep;116(9):1489-97. Epub 2010 mai 26
- PMID:
- 20505157
Ferrari S, Sundby Hall K, Luksch R, Tienghi A, Wiebe T, Fagioli F, Alvegard T A, Brach Del Prever A, Tamburini A, Alberghini M, Gandola L, Mercuri M, Capanna R, Mapelli S, Prete A, Carli M, Picci P, Barbieri E, Bacci G, Smeland S
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol.
Ann Oncol 2010 Nov. Epub 2010 nov 8
- PMID:
- 21059639
Ottaviano Laura, Schaefer Karl-Ludwig, Gajewski Melanie, Huckenbeck Wolfgang, Baldus Stefan, Rogel Uwe, Mackintosh Carlos, de Alava Enrique, Myklebost Ola, Kresse Stine H, Meza-Zepeda Leonardo A, Serra Massimo, Cleton-Jansen Anne-Marie, Hogendoorn Pancras C W, Buerger Horst, Aigner Thomas, Gabbert Helmut E, Poremba Christopher
Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort.
Genes Chromosomes Cancer 2010 Jan;49(1):40-51.
- PMID:
- 19787792
Hogendoorn P C W, PubMed.ItemsChoiceType2[], Athanasou N, Bielack S, De Alava E, Dei Tos A P, Ferrari S, Gelderblom H, Grimer R, Hall K Sundby, Hassan B, Hogendoorn P C W, Jurgens H, Paulussen M, Rozeman L, Taminiau A H M, Whelan J, Vanel D
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol 2010 May;21 Suppl 5():v204-13.
- PMID:
- 20555083
Abeler VM and Nenodovic M
Diagnostic Immunohistochemistry in Uterine Sarcomas: A study of 397 Cases
Int J Gynecol Pathol
Anfinsen KP, Grotmol T, Bruland OS, Jonasdottir TJ
Breed specific incidence rates of canine primary bone tumours-a population based survey of dogs in Norway
Canadian Journal of Veterinary Research
Buddingh EP, Marieke L, Kuijjer ML, Duim RAJ, Burger H, Agelopolus K, Myklebost O, Serra M, Hogendoorn PCW, Lankester AC, Cleton-Jansen AM:
Metastasis suppression by tumor-infiltration macrophages in high-grade osteosarcoma
Clin Cancer Res
Dahle J, Abbas N, Bruland OS, Larsen RH
Toxicity abd relative biological effectiveness of alpha emitting radioimmunocojugates
Current Radiopharmaceuticals
Zaikova O, Fosså SD, Bruland OS, Giercksky KE, Sandstad B, Skjeldahl S
Radiotherapy or surgery for spine metastases: a population-based study of 903 patients in the South-Eastern Region of Norway
Acta Orthopaedica
König M, Mork J, Hall KS, Osnes T, Meling T
Multimodal Treatment of osteogenic sarcoma of the jaw
Skull Base 2010, 20(3):207-12
Müller CR, Namløs H, Smeland S, Sæter G, Bjerkehagen B, Bjerner J, Holden M, Bruland OS, Myklebost O.
Characterization of Treatment Response to Interferon-alpha in Osteosarcoma Xenografts.
J Cancer Sci Ther 2. 2010; 033-42
Forskningsprosjekter
Strålebehandling av bløtvevssarkomer: planlegging og evaluering med PET og MRI
Jan Rødal, Oslo universitetssykehus HF
- Prosjektperiode:
- 2009 - 2013
- Deltakende helseregion:
- HSØ
Fotokjemisk internalisering som behandlingsmetode for leiomyosarkom
Simen Sellevold, Oslo universitetssykehus HF
- Prosjektperiode:
- 2010 - 2014
- Deltakende helseregion:
- HSØ
Response evaluation with PET-CT in GIST
Mona Elisabeth Revheim, Oslo universitetssykehus HF
- Prosjektperiode:
- 2010 - 2012
- Deltakende helseregion:
- HSØ
Strålebehandling av bløtvevssarkomer: betydning for lokalt recidiv og prognose
Nina Jebsen, Internasjonal institusjon
- Prosjektperiode:
- 2008 - 2012
- Deltakende helseregion:
- HV HSØ
Sekundære sarkomer
Bodil Bjerkehagen, Oslo universitetssykehus HF
- Prosjektperiode:
- 2008 - 2013
- Deltakende helseregion:
- HSØ
Biologisk tilpasset terapi mot ben- og bindevevskreft
Hege Ohma Onstad, Oslo universitetssykehus HF
- Prosjektperiode:
- 2005 - 2011
- Deltakende helseregion:
- HSØ
Prognostiske markører hos osteosarkompasienter
Christoph Müller, Oslo universitetssykehus HF
- Prosjektperiode:
- 2004 - 2011
- Deltakende helseregion:
- HSØ
